klinische pädiatrie
130330
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Klinische Pädiatrie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Board
Table of Contents
German National License
Imprint
Media
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Job Board
Job Opportunities
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
Issues
Current Issue
Free Sample Issue (01/2024)
Related Books
Pädiatrie
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
X
Y
Z
Wagner, F
Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias
Waha, A
Giant cell glioblastoma does not represent a distinct entity but stratifies into different genetically defined entities
Wegert, J
TRIM28 haploinsufficiency predisposes to Wilms tumor
Weiss, JM
Too little is too much: Leukemogenesis in the Gata2 syndrome
Analyzing the effects of oncogenic SHP2 on apoptosis signaling during malignant transformation
Welte, K
iPSC Model of Stepwise Leukemia Development in Congenital Neutropenia Reveals BAALC as a Key Mediator of Leukemogenesis
Downstream effect of CSF3R and RUNX1 mutations that underlie leukemic transformations in congenital neutropenia (CN)
CRISPR/Cas9 Gene-modification Platform of ELANE Mutations in iPSCs and HSPCs of Severe Congenital Neutropenia Patients
GADD45b plays an essential role in the G-CSF triggered granulocytic differentiation of human hematopoietic cells
NAMPT-mediated LMO2 deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis
Wiedey, A
Giant cell glioblastoma does not represent a distinct entity but stratifies into different genetically defined entities
Wilhelm, A
Investigating HDACi and dnTaspase1 for the treatment of t(4;11) leukemic cells
Williams, O
Targeting c-MYB in Acute Leukaemia through Drug Repositioning
Drug Repositioning in Infant Leukaemia
Epigenetics profiling for minimal residual disease in paediatric acute myeloid leukaemia
Williamson, D
Genomic characterisation of lineage switched MLL-rearranged leukemias
Winterberg, D
FOS and FOSB are linked with CNS-infiltration and inferior prognosis in childhood T-cell acute lymphoblastic leukemia
Witt, O
Functional analysis of class I HDAC inhibition in group 3 medulloblastoma to identify synergistic drug combinations
Wu, Y
Analyzing the therapeutic efficacy of navitoclax and MCL-1 inhibitors in juvenile myelomonyctic leukemia
Analyzing the effects of oncogenic SHP2 on apoptosis signaling during malignant transformation